Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Ossium Health, Inc.
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
City of Hope Medical Center
Emory University
Shanghai Pudong Hospital
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Northwestern University